Skip to main content

Table 1 Clinical and biological variables of 102 subjects with chronic lymphocytic leukemia

From: NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia

Characteristic Value (%)
Age
  ≤ 60 years 58 (56.9)
  > 60 years 44 (43.1)
Sex
 Male 69 (67.6)
 Female 33 (32.4)
Binet stage
 A 38 (37.2)
 B 33 (32.4)
 C 31 (30.4)
Lymphocytes
  < 50 × 109/L 71 (69.6)
  ≥ 50 × 109/L 31 (30.4)
LDH
  ≤ ULN 79 (77.5)
  > ULN 20 (22.5)
β2-MG
  ≤ ULN 34 (33.3)
  > ULN 68 (66.7)
CD38 (n = 100)
  < 30% 75 (75.0)
  ≥ 30% 25 (25.0)
ZAP-70 (n = 100)
  < 20% 55 (55.0)
  ≥ 20% 45 (45.0)
IGHV (n = 101)
 Mutated 61 (60.4)
 Unmutated 40 (39.6)
p53 aberrations
 No TP53 mutation or p53 deletion 78 (76.4)
TP53 mutation or p53 deletion 24 (23.5)
del (11q22.3) (n = 93)
 Negative 78 (83.9)
 Positive 15 (16.1)
del (13q14) (n = 65)
 Negative 39 (60.0)
 Positive 26 (40.0)
+ 12 (n = 81)
 Negative 69 (85.2)
 Positive 12 (14.8)